1. Tang L, Cheng J. Nonporous silica nanoparticles for nanomedicine application. Nano Today. 2013;8(3):290–312. https://doi.org/10.1016/j.na ntod.2013.04.007.
2. Napierska D, Thomassen LC, Lison D, Martens JA, Hoet PH. The nanosilica hazard: another variable entity. Part Fibre Toxicol. 2010;7(1):39. https://doi. org/10.1186/1743-8977-7-39.
3. Murugadoss S, Lison D, Godderis L, Van Den Brule S, Mast J, Brassinne F,et al. Toxicology of silica nanoparticles: an update. Arch Toxicol. 2017;91(9): 2967–3010. https://doi.org/10.1007/s00204-017-1993-y.
4. Khanna P, Ong C, Bay BH, Baeg GH. Nanotoxicity: an interplay of oxidative stress, inflammation and cell death. Nanomaterials. 2015;5(3):1163–80. https://doi.org/10.3390/nano5031163.
5. Stern ST, Adiseshaiah PP, Crist RM. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol. 2012;9(1):20. https://doi.org/10.1186/1743-8977-9-20.
6. Wang F, Gómez-Sintes R, Boya P. Lysosomal membrane permeabilization and cell death. Traffic (Copenhagen, Denmark). 2018;19(12):918–31. https:// doi.org/10.1111/tra.12613.
7. Uemura E, Yoshioka Y, Hirai T, Handa T, Nagano K, Higashisaka K, et al. Relationship between size and surface modification of silica particles and enhancement and suppression of inflammatory cytokine production by lipopolysaccharide- or peptidoglycan-stimulated RAW264.7 macrophages. J Nanopart Res. 2016;18(6):165. https://doi.org/10.1007/s11051-016-3475-1.
8. Kusaka T, Nakayama M, Nakamura K, Ishimiya M, Furusawa E, Ogasawara K. Effect of silica particle size on macrophage inflammatory responses. PLOS ONE. 2014;9(3):e92634. https://doi.org/10.1371/journal.pone.0092634.
9. Forman HJ, Torres M. Reactive oxygen species and cell signaling. Am J Respir Crit Care Med. 2002;166(supplement_1):S4–8. https://doi.org/10.1164/ rccm.2206007.
10. Lambeth JD. Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr Opin Hematol. 2002;9(1):11–7. https://doi.org/1 0.1097/00062752-200201000-00003.
11. Oakley FD, Abbott D, Li Q, Engelhardt JF. Signaling components of redox active endosomes: the redoxosomes. Antioxid Redox Signal. 2009;11(6): 1313–33. https://doi.org/10.1089/ars.2008.2363.
12. Bedard K, Krause K-H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87(1):245–313. https://doi.org/10.1152/physrev.00044.2005.
13. Henderson RF. Use of bronchoalveolar lavage to detect lung damage. Environ Health Perspect. 1984;56:115–29. https://doi.org/10.1289/ehp.8456115.
14. Driscoll KE, Hassenbein DG, Carter J, Poynter J, Asquith TN, Grant RA, et al. Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after mineral dust exposure. Am J Respir Cell Mol Biol. 1993;8(3):311–8. https://doi.org/1 0.1165/ajrcmb/8.3.311.
15. Schmal H, Shanley TP, Jones ML, Friedl HP, Ward PA. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol. 1996;156(5):1963–72.
16. Ortiz LA, Lasky J, Lungarella G, Cavarra E, Martorana P, Banks WA, et al. Upregulation of the p75 but not the p55 TNF-α receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am J Respir Cell Mol Biol. 1999;20(4):825–33. https://doi.org/10.1165/ajrcmb.20.4.3193.
17. Mossman BT, Churg A. Mechanisms in the Pathogenesis of Asbestosis and Silicosis. Am J Respir Crit Care Med. 1998;157(5):1666–80. https://doi.org/1 0.1164/ajrccm.157.5.9707141.
18. Papadopoulos C, Kirchner P, Bug M, Grum D, Koerver L, Schulze N, et al. VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy. EMBO J. 2017;36(2):135–50. https://doi. org/10.15252/embj.201695148.
19. Maejima I, Takahashi A, Omori H, Kimura T, Takabatake Y, Saitoh T, et al. Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J. 2013;32(17):2336–47. https://doi.org/10.1038/ emboj.2013.171.
20. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal. 2009;11(6):1289–99. https://doi. org/10.1089/ars.2008.2333.
21. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD(P) H oxidase assembly attenuates vascular O2 and systolic blood pressure in mice. Circ Res. 2001;89(5):408–14. https://doi.org/10.1161/ hh1701.096037.
22. Wottrich R, Diabaté S, Krug HF. Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co- culture. Int J Hyg Environ Health. 2004;207(4):353–61. https://doi.org/1 0.1078/1438-4639-00300.
23. Napierska D, Thomassen LCJ, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small. 2009;5(7):846–53. https://doi.org/10.1002/ smll.200800461.
24. Costantini LM, Gilberti RM, Knecht DA. The phagocytosis and toxicity of amorphous silica. PLOS ONE. 2011;6(2):e14647. https://doi.org/10.1371/ journal.pone.0014647.
25. Kaewamatawong T, Kawamura N, Okajima M, Sawada M, Morita T, Shimada A. Acute pulmonary toxicity caused by exposure to colloidal silica: particle size dependent pathological changes in mice. Toxicol Pathol. 2005;33(7): 745–51. https://doi.org/10.1080/01926230500416302.
26. Aits S, Kricker J, Liu B, Ellegaard A-M, Hämälistö S, Tvingsholm S, et al. Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay. Autophagy. 2015;11(8):1408–24. https://doi.org/10.1 080/15548627.2015.1063871.
27. Yoshida T, Yoshioka Y, Matsuyama K, Nakazato Y, Tochigi S, Hirai T, et al. Surface modification of amorphous nanosilica particles suppresses nanosilica-induced cytotoxicity, ROS generation, and DNA damage in various mammalian cells. Biochem Biophys Res Commun. 2012;427(4):748–52. https://doi.org/10.1016/j.bbrc.2012.09.132.
28. Lu X, Jin T, Zheng J, Fan X. The size and surface modification of amorphous silica particles affect the biological processes in murine macrophages. J Nanosci Nanotechnol. 2017;17(2):954–67. https://doi. org/10.1166/jnn.2017.12811.
29. Marzaioli V, Aguilar-Pimentel JA, Weichenmeier I, Luxenhofer G,Wiemann M, Landsiedel R, et al. Surface modifications of silic ananoparticles are crucial for their inert versus proinflammatory and immunomodulatory properties. Int J Nanomedicine. 2014;9:2815–32. https://doi.org/10.2147/IJN.S57396.
30. Kurtz-Chalot A, Klein JP, Pourchez J, Boudard D, Bin V, Alcantara GB, et al. Adsorption at cell surface and cellular uptake of silica nanoparticles with different surface chemical functionalizations: impact on cytotoxicity. J Nanopart Res. 2014;16(11):2738. https://doi.org/10.1007/s11051-014-2738-y.
31. Yu T, Malugin A, Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano. 2011;5(7):5717–28. https:// doi.org/10.1021/nn2013904.
32. Morris AS, Adamcakova-Dodd A, Lehman SE, Wongrakpanich A, Thorne PS, Larsen SC, et al. Amine modification of nonporous silica nanoparticles reduces inflammatory response following intratracheal instillation in murine lungs. Toxicol Lett. 2016;241:207–15. https://doi. org/10.1016/j.toxlet.2015.11.006 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691407/pdf/nihms744010.pdf.
33. Nemmar A, Nemery B, Hoet PHM, Rooijen NV, Hoylaerts MF. Silica particles enhance peripheral thrombosis. Am J Respir Crit Care Med. 2005;171(8):872–9. https://doi.org/10.1164/rccm.200409-1202OC.
34. dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small. 2011;7(23):3341–9. https://doi.org/10.1002/smll.201101076.
35. Giovanni M, Yue J, Zhang L, Xie J, Ong CN, Leong DT. Pro-inflammatory responses of RAW264.7 macrophages when treated with ultralow concentrations of silver, titanium dioxide, and zinc oxide nanoparticles. J Hazard Mater. 2015;297:146–52. https://doi.org/10.1016/j. jhazmat.2015.04.081.
36. Morishige T, Yoshioka Y, Inakura H, Tanabe A, Yao X, Narimatsu S, et al. The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture. Biomaterials. 2010;31(26):6833–42. https://doi.org/10.101 6/j.biomaterials.2010.05.036.
37. Hamilton RF Jr, Thakur SA, Holian A. Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med. 2008;44(7):1246–58. https://doi.org/10.1 016/j.freeradbiomed.2007.12.027.
38. Li Q, Harraz MM, Zhou W, Zhang LN, Ding W, Zhang Y, et al. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol Cell Biol. 2006;26(1):140–54. https://doi.org/10.112 8/MCB.26.1.140-154.2006.
39. Cachat J, Deffert C, Hugues S, Krause K-H. Phagocyte NADPH oxidase and specific immunity. Clin Sci. 2015;128(10):635–48. https://doi.org/10.1 042/cs20140635.
40. Marzaioli V, Groß CJ, Weichenmeier I, Schmidt-Weber CB, Gutermuth J, Groß O, et al. Specific surface modifications of silica nanoparticles diminish inflammasome activation and in vivo expression of selected inflammatory genes. Nanomaterials (Basel). 2017;7(11):355. https://doi.org/10.3390/nano7110355.
41. Rao KMK, Porter DW, Meighan T, Castranova V. The sources of inflammatory mediators in the lung after silica exposure. Environ Health Perspect. 2004; 112(17):1679–85. https://doi.org/10.1289/ehp.7295.
42. Skowyra ML, Schlesinger PH, Naismith TV, Hanson PI. Triggered recruitment of ESCRT machinery promotes endolysosomal repair. Science. 2018; 360(6384):eaar5078. https://doi.org/10.1126/science.aar5078.
43. Nishijima N, Hirai T, Misato K, Aoyama M, Kuroda E, Ishii KJ, et al. Human scavenger receptor A1-mediated inflammatory response to silica particle exposure is size specific. Front Immunol. 2017;8:379. https://doi.org/10.3389/ fimmu.2017.00379.
44. Tsugita M, Morimoto N, Tashiro M, Kinoshita K, Nakayama M. SR-B1 is a silica receptor that mediates canonical inflammasome activation. Cell Reports. 2017;18(5):1298–311. https://doi.org/10.1016/j.celrep.2017.01.004.
45. Oberdorster G. Lung particle overload: implications for occupational exposures to particles. Regul Toxicol Pharmacol. 1995;21(1):123–35. https:// doi.org/10.1006/rtph.1995.1017.
46. European Centre for Ecotoxicology and Toxicology of Chemicals. Poorly Soluble Particles/Lung Overload. Technical Report No., 122 2013.
47. Takahashi E, Indalao IL, Sawabuchi T, Mizuno K, Sakai S, Kimoto T, et al. Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus. Comp Immunol Microbiol Infect Dis. 2018;56:6–13. https://doi.org/10.1016/j.cimid.2017.11.002.
48. Indalao IL, Sawabuchi T, Takahashi E, Kido H. IL-1β is a key cytokine that induces trypsin upregulation in the influenza virus–cytokine–trypsin cycle. Arch Virol. 2017;162(1):201–11. https://doi.org/10.1007/s00705-016-3093-3.
49. Sakamoto K, Hashimoto N, Kondoh Y, Imaizumi K, Aoyama D, Kohnoh T, et al. Differential modulation of surfactant protein D under acute and persistent hypoxia in acute lung injury. Am J Phys Lung Cell Mol Phys. 2012; 303(1):L43–53. https://doi.org/10.1152/ajplung.00061.2012.
50. Ando A, Hashimoto N, Sakamoto K, Omote N, Miyazaki S, Nakahara Y, et al. Repressive role of stabilized hypoxia inducible factor 1α expression on transforming growth factor β-induced extracellular matrix production in lung cancer cells. Cancer Sci. 2019;110(6):1959–73. https://doi.org/10.1111/cas.14027.
51. Li Q, Spencer NY, Oakley FD, Buettner GR, Engelhardt JF. Endosomal Nox2 facilitates redox-dependent induction of NF-kappaB by TNF-alpha. Antioxid Redox Signal. 2009;11(6):1249–63. https://doi.org/10.1089/ars.2008.2407.
52. To EE, Vlahos R, Luong R, Halls ML, Reading PC, King PT, et al.Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy. Nat Commun. 2017;8(1):69. https://doi.org/1 0.1038/s41467-017-00057-x.